Avoro Capital Advisors LLC Q3 2020 Filing
Filed November 16, 2020
Portfolio Value
$7.0T
Holdings
46
Report Date
Q3 2020
Filing Type
13F-HR
All Holdings (46 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | —IMMUNOMEDICS INC | 26,250,000 | $2.2T | 31.71% | |
| 2 | MRTXEURMIRATI THERAPEUTICS INC | 4,343,000 | $721.2B | 10.25% | |
| 3 | HZNPHORIZON THERAPEUTICS PLC | 7,650,000 | $594.3B | 8.44% | |
| 4 | IOVAIOVANCE BIOTHERAPEUTICS INC | 9,536,039 | $313.9B | 4.46% | |
| 5 | ASNDASCENDIS PHARMA | 1,800,000 | $277.8B | 3.95% | |
| 6 | —MYOKARDIA INC | 1,885,000 | $257.0B | 3.65% | |
| 7 | ARGXARGENX SE | 902,500 | $236.9B | 3.37% | |
| 8 | SRPTSAREPTA THERAPEUTICS INC | 1,675,000 | $235.2B | 3.34% | |
| 9 | ARNAEURARENA PHARMACEUTICALS INC | 3,100,000 | $231.8B | 3.29% | |
| 10 | AM6AMICUS THERAPEUTICS INC | 10,850,000 | $153.2B | 2.18% | |
| 11 | XLRNACCELERON PHARMA INC | 1,350,000 | $151.9B | 2.16% | |
| 12 | BMRNBIOMARIN PHARMACEUTICAL INC | 1,750,000 | $133.1B | 1.89% | |
| 13 | —MERSANA THERAPEUTICS INC | 6,800,000 | $126.6B | 1.80% | |
| 14 | MDGLMADRIGAL PHARMACEUTICALS INC | 890,000 | $105.7B | 1.50% | |
| 15 | DCPHEURDECIPHERA PHARMACEUTICALS INC | 1,820,000 | $93.4B | 1.33% | |
| 16 | ADAPYADAPTIMMUNE THERAPEUTICS PLC | 11,000,000 | $87.8B | 1.25% | |
| 17 | KPTIEURKARYOPHARM THERAPEUTICS INC | 6,000,000 | $87.6B | 1.24% | |
| 18 | —CONSTELLATION PHARMACEUTICALS INC | 4,275,000 | $86.6B | 1.23% | |
| 19 | ADVMCHFADVERUM BIOTECHNOLOGIES INC | 8,000,000 | $82.4B | 1.17% | |
| 20 | TREURTRILLIUM THERAPEUTICS INC | 5,500,000 | $78.2B | 1.11% | |
| 21 | KURAKURA ONCOLOGY INC | 2,435,000 | $74.6B | 1.06% | |
| 22 | CBAYUSDCYMABAY THERAPEUTICS INC | 10,300,000 | $74.6B | 1.06% | |
| 23 | QUREUNIQURE NV | 1,750,000 | $64.5B | 0.92% | |
| 24 | PMVPPMV PHARMACEUTICALS INC | 1,850,000 | $57.6B | 0.82% | |
| 25 | RLMDRELMADA THERAPEUTICS INC | 1,500,000 | $56.4B | 0.80% | |
| 26 | OPHTEURIVERIC BIO INC | 7,250,000 | $40.9B | 0.58% | |
| 27 | ATNXEURATHENEX INC | 3,265,000 | $39.5B | 0.56% | |
| 28 | —MARINUS PHARMACEUTICALS INC | 3,000,000 | $38.5B | 0.55% | |
| 29 | XENEXENON PHARMACEUTICALS INC | 2,800,000 | $31.0B | 0.44% | |
| 30 | CUECUE BIOPHARMA INC | 1,870,000 | $28.1B | 0.40% | |
| 31 | ALTALTIMMUNE INC | 2,000,000 | $26.4B | 0.38% | |
| 32 | AMRNAMARIN CORP PLC | 6,000,000 | $25.3B | 0.36% | |
| 33 | —RETROPHIN INC | 1,325,000 | $24.5B | 0.35% | |
| 34 | RLAYRELAY THERAPEUTICS INC | 500,000 | $21.3B | 0.30% | |
| 35 | AVDLAVADEL PHARMACEUTICALS PLC | 4,200,000 | $21.2B | 0.30% | |
| 36 | RAPTEURRAPT THERAPEUTICS INC | 575,000 | $18.5B | 0.26% | |
| 37 | BDTXBLACK DIAMOND THERAPEUTICS INC | 602,500 | $18.2B | 0.26% | |
| 38 | —ZOGENIX INC | 875,000 | $15.7B | 0.22% | |
| 39 | RNAAVIDITY BIOSCIENCES INC | 545,000 | $15.3B | 0.22% | |
| 40 | —THERAPEUTICS ACQUISITION CORP | 1,000,000 | $14.4B | 0.20% | |
| 41 | GNCAQGENOCEA BIOSCIENCES INC | 5,084,184 | $11.6B | 0.17% | |
| 42 | 5E7ITEOS THERAPEUTICS INC | 460,000 | $11.3B | 0.16% | |
| 43 | FRXFENNEC PHARMACEUTICALS INC | 1,670,000 | $10.1B | 0.14% | |
| 44 | —BCTG ACQUISITION CORP | 800,000 | $8.7B | 0.12% | |
| 45 | —ALIMERA SCIENCES INC | 415,999 | $2.0B | 0.03% | |
| 46 | KYMRKYMERA THERAPEUTICS INC | 49,400 | $1.6B | 0.02% |